Form 4: Confluent CEO Edward Kreps Executes Pre-Arranged Stock Sale Totaling $5.7 Million

Sentiment:

Insider Transaction Report 9 June 2025 4:47 PM

Confluent, Inc. CEO and Director Edward Jay Kreps converted and sold 232,500 shares of Class A Common Stock for approximately $5.7 million, as part of a pre-scheduled 10b5-1 trading plan.

Summary

Edward Jay Kreps, CEO and Director of Confluent, Inc., converted 232,500 shares of Class B Common Stock into Class A Common Stock on June 5, 2025.
Immediately following the conversion, Mr. Kreps sold all 232,500 newly converted Class A shares.
The sales were executed in two tranches: 204,858 shares at an average price of $24.43 per share (ranging from $23.88 to $24.87) and 27,642 shares at an average price of $24.98 per share (ranging from $24.88 to $25.08).
The total proceeds from these sales amount to approximately $5,695,500.
These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on August 15, 2024.
Following these transactions, Mr. Kreps directly holds 452,488 shares of Class A Common Stock and 15,142,293 shares of Class B Common Stock.
Additionally, Mr. Kreps indirectly holds 149,984 shares of Class B Common Stock through The Edward J. Kreps and Jamaica H. Kreps 2018 Revocable Trust, and 2,000,000 shares of Class B Common Stock through two GST Exempt Trusts under The Kreps Family 2019 Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the fact that it was conducted under a pre-arranged 10b5-1 trading plan mitigates concerns, indicating a planned liquidity event rather than a reaction to adverse company news. The CEO still retains a very substantial holding.

Positives

The sale was conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not a reaction to recent negative company developments, which can mitigate concerns about insider selling.
The conversion of Class B to Class A shares and subsequent sale demonstrates liquidity for the insider's holdings.

Negatives

A significant sale of shares by a CEO, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.

Risks

Potential negative market perception due to a large insider sale, despite the 10b5-1 plan.
Fluctuations in stock price between the adoption of the 10b5-1 plan and the execution of the sale could impact the actual proceeds received by the insider.

Future Outlook

Industry Context

This Form 4 filing details a routine insider transaction under a pre-arranged trading plan and does not provide information relevant to broader industry trends or competitive analysis.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Authorization of Attorney-in-Fact	Edward Jay Kreps granted a Power of Attorney to several individuals at Confluent, Inc. (Weilyn Wood, Brianna Murray, Simona Katcher, Kong Phan, Claire Lum) to manage his EDGAR account and execute Forms 3, 4, and 5 on his behalf. This streamlines compliance with Section 16(a) of the Securities Exchange Act of 1934.	06/05/2025	This is a standard administrative measure to ensure timely and accurate SEC filings for insider transactions, enhancing compliance efficiency.

Related Party Transactions

The sale of shares by Edward Jay Kreps, a director and CEO of Confluent, Inc., constitutes a related party transaction (insider transaction). However, it is conducted under a Rule 10b5-1 plan, which provides an affirmative defense against insider trading allegations.

Stakeholder Impact

Shareholders: The sale by the CEO might lead to short-term negative sentiment if not fully understood as a pre-planned transaction. However, the 10b5-1 plan helps to alleviate concerns about the CEO's confidence in the company. The CEO retains a significant stake, aligning his interests with shareholders.
Employees: No direct impact mentioned.
Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

Date	Description
2018	Establishment of The Edward J. Kreps and Jamaica H. Kreps 2018 Revocable Trust, which indirectly holds Class B Common Stock.
2019	Establishment of The Kreps Family 2019 Irrevocable Trust, which indirectly holds Class B Common Stock.
08/15/2024	Date the 10b5-1 trading plan was adopted by Edward Jay Kreps.
06/05/2025	Date of the reported stock conversion and sale transactions.
06/05/2025	Date of execution of the Power of Attorney by Edward Jay Kreps.
06/09/2025	Date the Form 4 was signed by the Attorney-in-Fact.

Recommendation

hold

Keywords

Confluent, CFLT, Edward Kreps, CEO, Director, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Class A Common Stock, Class B Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.